Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P10s-PADRE vaccine in metastatic cancer
NCT03003195Phase 2Withdrawn
- Sponsor
- University of Arkansas
- Start
- Mar 2021
- Primary completion
- Mar 2021
- Modality
- Peptides, Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of P10s-PADRE in metastatic cancer, sponsored by University of Arkansas. Planned start Mar 2021; status: withdrawn.
02
Drugs
P10s-PADRE
03
Conditions
metastatic cancer
Beyond the preview
Go deeper on NCT03003195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03003195.